Generic Name and Formulations:
Theophylline 80mg per 15mL; liq; contains alcohol 20%; tutti frutti flavor.
Indications for ELIXOPHYLLIN:
Treatment of symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases (eg, emphysema, chronic bronchitis).
Adults and Children:
Individualize. Calculate based on ideal body weight. <1yr: premature neonates: <24 days: 1mg/kg every 12hrs; ≥24 days: 1.5mg/kg every 12hrs. Full term infants and infants up to 52 weeks old: total dose (mg) = [(0.2 x age in weeks) + 5] x kg body weight; up to age 26 weeks, divide dose into 3 equal amounts given at 8hr intervals; >26 weeks, divide dose into 4 equal amounts given at 6hr intervals. Adjust to maintain peak steady state serum theophylline concentration of 5–10mcg/mL in neonates and 10–15mcg/mL in older infants. Children (1–15yrs) and adults (16–60yrs) without risk factors for impaired clearance: children<45kg: initially 12–14mg/kg/day up to max 300mg/day divided every 4–6hrs; after 3 days, if tolerated, increase dose to 16mg/kg/day up to max 400mg/day divided every 4–6hrs; after 3 more days, if tolerated, increase to 20mg/kg/day up to max 600mg/day divided every 4–6hrs. Children >45kg and adults: initially 300mg/day divided every 6–8hrs; after 3 days, if tolerated, increase to 400mg/day divided every 6–8hrs; after 3 more days, if tolerated, increase to 600mg/day divided every 6–8hrs. Patients with risk factors for impaired clearance, elderly, and in those whom it is not feasible to monitor theophylline concentrations: 1–15yrs: final dose not exceed 16mg/kg/day up to max 400mg/day; ≥16yrs: final dose not exceed 400mg/day. Loading dose for acute bronchodilation: a single 5mg/kg dose. Dose adjustments based on theophylline concentrations: see literature.
Active peptic ulcer. Arrhythmias. Seizure disorders. Hepatic dysfunction. CHF. Acute pulmonary edema. Cor pulmonale. Hypothyroidism. Fever. Sepsis. Shock. Monitor serum levels (blood sample should be obtained at time of expected peak serum theophylline concentration; 1–2 hours after a dose at steady-state); do not try to maintain non-tolerated doses. Monitor serum theophylline concentrations at 6 month intervals for rapidly growing children and yearly for all others. Acutely ill: monitor more frequently (eg, every 24 hours). Slow or rapid metabolizers. Reduced renal function in infants <3 months old. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
See literature. Smokers have increased metabolism. Potentiated by quinolones, macrolides, cimetidine, alcohol, allopurinol, estrogen oral contraceptives, tacrine, interferon alpha, disulfiram, fluvoxamine, verapamil, mexiletine, methotrexate, pentoxifylline, propafenone, propranolol. ticlopidine, thiabendazole. Antagonized by aminoglutethimide, phenytoin, rifampin, barbiturates, carbamazepine, ritonavir, sucralfate, isoproterenol, moricizine, sulfinpyrazone. Avoid β-blockers. Antagonizes lithium, benzodiazepines, pancuronium, adenosine. Toxicity with sympathomimetics. Seizures with ketamine. Arrhythmias with halothane.
GI upset, headache, CNS stimulation, diuresis, arrhythmias, seizures, others.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy